Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Panfeng Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, 36 Lushan Road, Yuelu District, Changsha 410081, Hunan, China. Hauptthemen laut MEDLINE: Insulin, Hypoglycemic Agents, Cell-Penetrating Peptides, Blood Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Latroeggtoxin-VI (LETX-VI) was previously shown to cross cell membrane and its C-terminal sequence is the functional peptide segment (FPS) for the transmembrane action. This proof-of-concept study aimed to confirm the promoting-effect of FPS as well as LETX-VI on nasal insulin absorption.
Methods
After FPS and LETX-VI were intranasally coadministrated with insulin to mice, respectively, the changes in hypoglycemic effect of the insulin were determined.
Results
Compared with insulin alone, the mixture of insulin and 0.5 mM LETX-VI decreased the peak blood glucose concentration by 33.14% (P < .05); coadministration of insulin and 4 mM FPS decreased the peak value of blood glucose by 19.88% (P < .05). Besides, addition of 4 mM FPS decreased the AUC0–90 min value from 1062.50 of insulin alone to 926.17, which was significantly lower than that of the blank control (P < .05); FPS made the insulin exert hypoglycemic effect earlier and did not change the end time of the hypoglycemic action.
Conclusion
Both LETX-VI and FPS are able to efficiently facilitate nasal insulin absorption and thus enhance the hopyglycemic effect of insulin. Relatively, FPS has a much smaller molecular weight and thus is more promising in the transmembrane delivery of drugs including insulin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, 36 Lushan Road, Yuelu District, Changsha 410081, Hunan, China.
ORCID-Profile: Xianchun Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yin, P., Sun, M., Chen, S., & Wang, X. (2025). Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf126
Vancouver
Yin P, Sun M, Chen S, Wang X. Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf126
BibTeX
@article{Yin2025,
author = {Yin, Panfeng and Sun, Minglu and Chen, Si and Wang, Xianchun},
title = {Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf126}
}
EUVIMED